Biogen Launches High-Dose Spinraza Trial In Evrysdi Treated Patients: What You Need To Know
Novartis Touts More Positive Zolgensma Data In Spinal Muscular Atrophy Patients
Why Scholar Rock Shares Dropped Despite Positive Apitegromab Data In Spinal Muscular Atrophy
Scholar Rock Reports Apitegromab Data In Spinal Muscular Atrophy